Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Published 2013 View Full Article

Authors

Keywords

Journal

LANCET

Volume 381, Issue 9877, Pages 1541-1550

Publisher

Elsevier BV

Online

2013-03-18

DOI

10.1016/s0140-6736(13)60250-0

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

LANCET

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Find the ideal target journal for your manuscript